Fluorescent contrast agents for tumor surgery (Review)
- Authors:
- Qi Xiao
- Tianming Chen
- Shilin Chen
-
Affiliations: School of Life Science, Nanjing Normal University, Nanjing, Jiangsu 210046, P.R. China, Department of Surgery, Nanjing Medical University Third Affiliated Hospital, Nanjing, Jiangsu 211166, P.R. China, Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu 210009, P.R. China - Published online on: July 4, 2018 https://doi.org/10.3892/etm.2018.6401
- Pages: 1577-1585
-
Copyright: © Xiao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
 |
|
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Aliperti LA, Predina JD, Vachani A and Singhal S: Local and systemic recurrence is the Achilles heel of cancer surgery. Ann Surg Oncol. 18:603–607. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang JX, Keating JJ, Jesus EM, Judy RP, Madajewski B, Venegas O, Okusanya OT and Singhal S: Optimization of the enhanced permeability and retention effect for near-infrared imaging of solid tumors with indocyanine green. Am J Nucl Med Mol Imaging. 5:390–400. 2015.PubMed/NCBI | |
|
Tansi FL, Rüger R, Böhm C, Kontermann RE, Teichgraeber UK, Fahr A and Hilger I: Potential of activatable FAP-targeting immunoliposomes in intraoperative imaging of spontaneous metastases. Biomaterials. 88:70–82. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Fedor D, Johnson WR and Singhal S: Local recurrence following lung cancer surgery: Incidence, risk factors, and outcomes. Surg Oncol. 22:156–161. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zaman M, Bilal H, Woo CY and Tang A: In patients undergoing video-assisted thoracoscopic surgery excision, what is the best way to locate a subcentimetre solitary pulmonary nodule in order to achieve successful excision? Interact Cardiovasc Thorac Surg. 15:266–272. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Chella A, Lucchi M, Ambrogi MC, Menconi G, Melfi FM, Gonfiotti A, Boni G and Angeletti CA: A pilot study of the role of TC-99 radionuclide in localization of pulmonary nodular lesions for thoracoscopic resection. Eur J Cardiothoracic Surg. 18:17–21. 2000. View Article : Google Scholar | |
|
Powell TI, Jangra D, Clifton JC, Lara-Guerra H, Church N, English J, Evans K, Yee J, Coxson H, Mayo JR and Finley RJ: Peripheral lung nodules: Fluoroscopically guided video-assisted thoracoscopic resection after computed tomography-guided localization using platinum microcoils. Ann Surg. 240:481–489. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Eichfeld U, Dietrich A, Ott R and Kloeppel R: Video-assisted thoracoscopic surgery for pulmonary nodules after computed tomography-guided marking with a spiral wire. Ann Thorac Surg. 79:313–317. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Licha K, Riefke B, Ebert B and Grötzinger C: Cyanine dyes as contrast agents in biomedical optical imaging. Acad Radiol. 9 Suppl 2:S320–S322. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Luker GD and Luker KE: Optical imaging: Current applications and future directions. J Nucl Med. 49:1–4. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, Kelder W, Sarantopoulos A, de Jong JS, Arts HJ, van der Zee AG, et al: Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: First in-human results. Nat Med. 17:1315–1319. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Polom K, Murawa D, Rho YS, Nowaczyk P, Hünerbein M and Murawa P: Current trends and emerging future of indocyanine green usage in surgery and oncology: A literature review. Cancer. 117:4812–4822. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
van Leeuwen FW, Hardwick JC and van Erkel AR: Luminescence-based imaging approaches in the field of interventional molecular imaging. Radiol. 276:12–29. 2015. View Article : Google Scholar | |
|
KleinJan GH, Bunschoten A, van den Berg NS, Olmos RA, Klop WM, Horenblas S, van der Poel HG, Wester HJ and van Leeuwen FW: Fluorescence guided surgery and tracer-dose, fact or fiction? Eur J Nucl Med Mol Imaging. 43:1857–1867. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Brülisauer M, Moneta G, Jager K and Bollinger A: Infrared fluorescence videomicroscopy with indocyanine green (Cardiogreen). Adv Exp Med Biol. 220:219–221. 1987.PubMed/NCBI | |
|
Chen CY, Fancher RM, Ruan Q, Marathe P, Rodrigues AD and Yang Z: A liquid chromatography tandem mass spectrometry method for the quantification of indocyanine green in dog plasma and bile. J Pharm Biomed Anal. 47:351–359. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Engel E, Schraml R, Maisch T, Kobuch K, König B, Szeimies RM, Hillenkamp J, Bäumler W and Vasold R: Light-induced decomposition of indocyanine green. Invest Ophthalmol Vis Sci. 49:1777–1783. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
van der Vorst JR, Schaafsma BE, Hutteman M, Verbeek FP, Liefers GJ, Hartgrink HH, Smit VT, Löwik CW, van de Velde CJ, Frangioni JV and Vahrmeijer AL: Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer. 119:3411–3418. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yokoyama N, Otani T, Hashidate H, Maeda C, Katada T, Sudo N, Manabe S, Ikeno Y, Toyoda A and Katayanagi N: Real-time detection of hepatic micrometastases from pancreatic cancer by intraoperative fluorescence imaging: Preliminary results of a prospective study. Cancer. 118:2813–2819. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Rajaraman P, Schwartz BS, Rothman N, Yeager M, Fine HA, Shapiro WR, Selker RG, Black PM and Inskip PD: Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults. Environ Health Perspect. 113:1209–1211. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Iida G, Asano K, Seki M, Ishigaki K, Teshima K, Yoshida O, Edamura K and Kagawa Y: Intraoperative identification of canine hepatocellular carcinoma with indocyanine green fluorescent imaging. J Small Anim Pract. 54:594–600. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gotoh K, Yamada T, Ishikawa O, Takahashi H, Eguchi H, Yano M, Ohigashi H, Tomita Y, Miyamoto Y and Imaoka S: A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation. J Surg Oncol. 100:75–79. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ishizawa T, Masuda K, Urano Y, Kawaguchi Y, Satou S, Kaneko J, Hasegawa K, Shibahara J, Fukayama M, Tsuji S, et al: Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma. Ann Surg Oncol. 21:440–448. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cherrick GR, Stein SW, Leevy CM and Davidson CS: Indocyanine green: Observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest. 39:592–600. 1960. View Article : Google Scholar : PubMed/NCBI | |
|
Cornelius CE, Ben-Ezzer J and Arias IM: Binding of sulfobromophthalein sodium (BSP) and other organic anions by isolated hepatic cell plasma membranes in vitro. Proc Soc Exp Biol Med. 124:665–667. 1967. View Article : Google Scholar : PubMed/NCBI | |
|
Hunton DB, Bollman JL and Hoffman HN: Studies of hepatic function with indocyanine green. Gastroenterology. 39:713–724. 1960.PubMed/NCBI | |
|
Leevy CM and Bender J: Physiology of dye extraction by the liver: Comparative studies of sulfobromophthalein and indocyanine green. Ann NY Acad Sci. 111:161–176. 1963. View Article : Google Scholar : PubMed/NCBI | |
|
Shibasaki Y, Sakaguchi T, Hiraide T, Morita Y, Suzuki A, Baba S, Setou M and Konno H: Expression of indocyanine green-related transporters in hepatocellular carcinoma. J Surg Res. 193:567–576. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Holt D, Okusanya O, Judy R, Venegas O, Jiang J, DeJesus E, Eruslanov E, Quatromoni J, Bhojnagarwala P, Deshpande C, et al: Intraoperative near-infrared imaging can distinguish cancer from normal tissue but not inflammation. PLoS One. 9:e1033422014. View Article : Google Scholar : PubMed/NCBI | |
|
Kosaka N, Mitsunaga M, Longmire MR, Choyke PL and Kobayashi H: Near infrared fluorescence-guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green. Int J Cancer. 129:1671–1677. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Maeda H, Nakamura H and Fang J: The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev. 65:71–79. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Madajewski B, Judy BF, Mouchli A, Kapoor V, Holt D, Wang MD, Nie S and Singhal S: Intraoperative near-infrared imaging of surgical wounds after tumor resections can detect residual disease. Clin Cancer Res. 18:5741–5751. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Shin EH, Li Y, Kumar U, Sureka HV, Zhang X and Payne CK: Membrane potential mediates the cellular binding of nanoparticles. Nanoscale. 5:5879–5886. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Matsumura Y and Maeda H: A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46:6387–6392. 1986.PubMed/NCBI | |
|
Heneweer C, Holland JP, Divilov V, Carlin S and Lewis JS: Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system. J Nucl Med. 52:625–633. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Fang C, Wang K, Zeng C, Chi C, Shang W, Ye J, Mao Y, Fan Y, Yang J, Xiang N, et al: Illuminating necrosis: From mechanistic exploration to preclinical application using fluorescence molecular imaging with indocyanine green. Sci Rep. 6:210132016. View Article : Google Scholar : PubMed/NCBI | |
|
Hyun H, Park MH, Owens EA, Wada H, Henary M, Handgraaf HJ, Vahrmeijer AL, Frangioni JV and Choi HS: Structure-inherent targeting of near-infrared fluorophores for parathyroid and thyroid gland imaging. Nat Med. 21:192–197. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yoneya S, Saito T, Komatsu Y, Koyama I, Takahashi K and Duvoll-Young J: Binding properties of indocyanine green in human blood. Invest Ophthalmol Vis Sci. 39:1286–1290. 1998.PubMed/NCBI | |
|
Baker KJ: Binding of sulfobromophthalein (BSP) sodium and indocyanine green (ICG) by plasma alpha-1 lipoproteins. Proc Soc Exp Biol Med. 122:957–963. 1966. View Article : Google Scholar : PubMed/NCBI | |
|
Janecki J and Krawcynski J: Labeling with indocyanine green of serum protein from normal persons and patients with acute viral hepatitis. Clin Chem. 16:1008–1011. 1970.PubMed/NCBI | |
|
Desmettre T, Devoisselle JM and Mordon S: Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophthalmol. 45:15–27. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Onda N, Kimura M, Yoshida T and Shibutani M: Preferential tumor cellular uptake and retention of indocyanine green for in vivo tumor imaging. Int J Cancer. 139:673–682. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
von Kleist L, Stahlschmidt W, Bulut H, Gromova K, Puchkov D, Robertson MJ, MacGregor KA, Tomilin N, Pechstein A, Chau N, et al: Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell. 146:471–484. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kaibori M, Matsui K, Ishizaki M, Iida H, Okumura T, Sakaguchi T, Inoue K, Ikeura T, Asano H and Kon M: Intraoperative detection of superficial liver tumors by fluorescence imaging using indocyanine green and 5-aminolevulinic acid. Anticancer Res. 36:1841–1849. 2016.PubMed/NCBI | |
|
Hill TK, Abdulahad A, Kelkar SS, Marini FC, Long TE, Provenzale JM and Mohs AM: Indocyanine green-loaded nanoparticles for image-guided tumor surgery. Bioconjug Chem. 26:294–303. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ishizuka M, Abe F, Sano Y, Takahashi K, Inoue K, Nakajima M, Kohda T, Komatsu N, Ogura S and Tanaka T: Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. Int Immunopharmacol. 11:358–365. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Nakamura M, Nishikawa J, Hamabe K, Goto A, Nishimura J, Shibata H, Nagao M, Sasaki S, Hashimoto S, Okamoto T and Sakaida I: Preliminary study of photodynamic diagnosis using 5-aminolevulinic acid in gastric and colorectal tumors. World J Gastroenterol. 21:6706–6712. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Leroy HA, Vermandel M, Lejeune JP, Mordon S and Reyns N: Fluorescence guided resection and glioblastoma in 2015: A review. Lasers Surg Med. 47:441–451. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kitada M, Ohsaki Y, Matsuda Y, Hayashi S and Ishibashi K: Photodynamic diagnosis of pleural malignant lesions with a combination of 5-aminolevulinic acid and intrinsic fluorescence observation systems. BMC Cancer. 15:1742015. View Article : Google Scholar : PubMed/NCBI | |
|
Friesen SA, Hjortland GO, Madsen SJ, Hirschberg H, Engebraten O, Nesland JM and Peng Q: 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review). Int J Oncol. 21:577–582. 2002.PubMed/NCBI | |
|
Colditz MJ and Jeffree RL: Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies. J Clin Neurosci. 19:1471–1474. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Colditz MJ, Leyen K and Jeffree RL: Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 2: Theoretical, biochemical and practical aspects. J Clin Neurosci. 19:1611–1616. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Eljamel S: 5-ALA fluorescence image guided resection of glioblastoma multiforme: A meta-analysis of the literature. Int J Mol Sci. 16:10443–10456. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Nokes B, Apel M, Jones C, Brown G and Lang JE: Aminolevulinic acid (ALA): Photodynamic detection and potential therapeutic applications. J Surg Res. 181:262–271. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yang X, Palasuberniam P, Kraus D and Chen B: Aminolevulinic acid-based tumor detection and therapy: Molecular mechanisms and strategies for enhancement. Int J Mol Sci. 16:25865–25880. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ponka P: Cell biology of heme. Am J Med Sci. 318:241–256. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Kemmner W, Wan K, Rüttinger S, Ebert B, Macdonald R, Klamm U and Moesta KT: Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J. 22:500–509. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hooda J, Cadinu D, Alam MM, Shah A, Cao TM, Sullivan LA, Brekken R and Zhang L: Enhanced heme function and mitochondrial respiration promote the progression of lung cancer cells. PloS One. 8:e634022013. View Article : Google Scholar : PubMed/NCBI | |
|
Gonçalves TL, Erthal F, Corte CL, Müller LG, Piovezan CM, Nogueira CW and Rocha JB: Involvement of oxidative stress in the pre-malignant and malignant states of cervical cancer in women. Clin Biochem. 38:1071–1075. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Neslund-Dudas C, Levin AM, Rundle A, Beebe-Dimmer J, Bock CH, Nock NL, Jankowski M, Datta I, Krajenta R, Dou QP, et al: Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancer. Prostate. 74:637–646. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Navone NM, Polo CF, Frisardi AL, Andrade NE and Battle AM: Heme biosynthesis in human breast cancer-mimetic ‘in vitro’ studies and some heme enzymic activity levels. Int J Biochem. 22:1407–1411. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Krieg RC, Fickweiler S, Wolfbeis OS and Knuechel R: Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro. Photochem Photobiol. 72:226–233. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Krieg RC, Messmann H, Rauch J, Seeger S and Knuechel R: Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells. Photochem Photobiol. 76:518–525. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Hinnen P, de Rooij FW, van Velthuysen ML, Edixhoven A, van Hillegersberg R, Tilanus HW, Wilson JH and Siersema PD: Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: A study in patients with (pre)malignant lesions of the oesophagus. Br J Cancer. 78:679–682. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Hinnen P, de Rooij FW, Terlouw EM, Edixhoven A, van Dekken H, van Hillegersberg R, Tilanus HW, Wilson JH and Siersema PD: Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid. Br J Cancer. 83:539–543. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Misawa Y, Tojo A and Shibuya M: Isolation of genes highly expressed in early and late stages of Friend virus-induced erythroleukemia in mice. Biochem Biophys Res Commun. 170:39–45. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Ito E, Yue S, Moriyama EH, Hui AB, Kim I, Shi W, Alajez NM, Bhogal N, Li G, Datti A, et al: Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer. Sci Transl Med. 3:67ra672011. View Article : Google Scholar | |
|
Dailey HA and Smith A: Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem J. 223:441–445. 1984. View Article : Google Scholar : PubMed/NCBI | |
|
Miyake M, Ishii M, Kawashima K, Kodama T, Sugano K, Fujimoto K and Hirao Y: siRNA-mediated knockdown of the heme synthesis and degradation pathways: Modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines. Photochem Photobiol. 85:1020–1027. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Teng L, Nakada M, Zhao SG, Endo Y, Furuyama N, Nambu E, Pyko IV, Hayashi Y and Hamada JI: Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy. Br J Cancer. 104:798–807. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Yang X, Li W, Palasuberniam P, Myers KA, Wang C and Chen B: Effects of silencing heme biosynthesis enzymes on 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy. Photochem Photobiol. 91:923–930. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Frezza C, Zheng L, Folger O, Rajagopalan KN, MacKenzie ED, Jerby L, Micaroni M, Chaneton B, Adam J, Hedley A, et al: Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature. 477:225–228. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ward PS and Thompson CB: Metabolic reprogramming: A cancer hallmark even warburg did not anticipate. Cancer Cell. 21:297–308. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ohgari Y, Nakayasu Y, Kitajima S, Sawamoto M, Mori H, Shimokawa O, Matsui H and Taketani S: Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: Relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. Biochem Pharmacol. 71:42–49. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Gibson SL, Nguyen ML, Havens JJ, Barbarin A and Hilf R: Relationship of delta-aminolevulinic acid-induced protoporphyrin IX levels to mitochondrial content in neoplastic cells in vitro. Biochem Biophys Res Commun. 265:315–321. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Gibson SL, Havens JJ, Foster TH and Hilf R: Time-dependent intracellular accumulation of delta-aminolevulinic acid, induction of porphyrin synthesis and subsequent phototoxicity. Photochem Photobiol. 65:416–421. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Nakanishi T, Ogawa T, Yanagihara C and Tamai I: Kinetic evaluation of determinant factors for cellular accumulation of protoporphyrin IX induced by external 5-aminolevulinic acid for photodynamic cancer therapy. J Pharm Sci. 104:3092–3100. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Krishnamurthy PC, Du G, Fukuda Y, Sun D, Sampath J, Mercer KE, Wang J, Sosa-Pineda B, Murti KG and Schuetz JD: Identification of a mammalian mitochondrial porphyrin transporter. Nature. 443:586–589. 2006.PubMed/NCBI | |
|
Zhao SG, Chen XF, Wang LG, Yang G, Han DY, Teng L, Yang MC, Wang DY, Shi C, Liu YH, et al: Increased expression of ABCB6 enhances protoporphyrin IX accumulation and photodynamic effect in human glioma. Ann Surg Oncol. 20:4379–4388. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Paterson JK, Shukla S, Black CM, Tachiwada T, Garfield S, Wincovitch S, Ernst DN, Agadir A, Li X, Ambudkar SV, et al: Human ABCB6 localizes to both the outer mitochondrial membrane and the plasma membrane. Biochemistry. 46:9443–9452. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Tsuchida M, Emi Y, Kida Y and Sakaguchi M: Human ABC transporter isoform B6 (ABCB6) localizes primarily in the Golgi apparatus. Biochem Biophys Res Commun. 369:369–375. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Matsumoto K, Hagiya Y, Endo Y, Nakajima M, Ishizuka M, Tanaka T and Ogura S: Effects of plasma membrane ABCB6 on 5-aminolevulinic acid (ALA)-induced porphyrin accumulation in vitro: Tumor cell response to hypoxia. Photodiagnosis Photodyn Ther. 12:45–51. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Robey RW, Steadman K, Polgar O and Bates SE: ABCG2-mediated transport of photosensitizers: Potential impact on photodynamic therapy. Cancer Biol Ther. 4:187–194. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Barron GA, Moseley H and Woods JA: Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition. J Photochem Photobiol B. 126:87–96. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ogawa M, Kosaka N, Choyke PL and Kobayashi H: H-type dimer formation of fluorophores: A mechanism for activatable, in vivo optical molecular imaging. ACS Chem Biol. 4:535–546. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tansi F, Kallweit E, Kaether C, Kappe K, Schumann C, Hilger I and Reissmann S: Internalization of near-infrared fluorescently labeled activatable cell-penetrating peptide and of proteins into human fibrosarcoma cell line HT-1080. J Cell Biochem. 116:1222–1231. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Rizzo LY, Theek B, Storm G, Kiessling F and Lammers T: Recent progress in nanomedicine: Therapeutic, diagnostic and theranostic applications. Curr Opin Biotechnol. 24:1159–1166. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tansi FL, Rüger R, Rabenhold M, Steiniger F, Fahr A, Kaiser WA and Hilger I: Liposomal encapsulation of a near-infrared fluorophore enhances fluorescence quenching and reliable whole body optical imaging upon activation in vivo. Small. 9:3659–3669. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Rüger R, Tansi FL, Rabenhold M, Steiniger F, Kontermann RE, Fahr A and Hilger I: In vivo near-infrared fluorescence imaging of FAP-expressing tumors with activatable FAP-targeted, single-chain Fv-immunoliposomes. J Control Release. 186:1–10. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Huang Y, Simms AE, Mazur A, Wang S, León NR, Jones B, Aziz N and Kelly T: Fibroblast activation protein-alpha promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions. Clin Exp Metastasis. 28:567–579. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lee HO, Mullins SR, Franco-Barraza J, Valianou M, Cukierman E and Cheng JD: FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC Cancer. 11:2452011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhi K, Shen X, Zhang H and Bi J: Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers. J Exp Clin Cancer Res. 29:662010. View Article : Google Scholar : PubMed/NCBI | |
|
Tommelein J, Verset L, Boterberg T, Demetter P, Bracke M and De Wever O: Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer. Front Oncol. 5:632015. View Article : Google Scholar : PubMed/NCBI | |
|
Garin-Chesa P, Old LJ and Rettig WJ: Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA. 87:7235–7239. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Albert MB, Steinberg WM and Henry JP: Elevated serum levels of tumor marker CA19-9 in acute cholangitis. Dig Dis Sci. 33:1223–1225. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Benamouzig R, Buffet C, Fourre C, Ink O, Moati F and Etienne JP: Serum levels of carbohydrate antigenic determinant (CA 19.9) in obstructive jaundice. Dig Dis Sci. 34:1640–1642. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Encabo G and Ruibal A: Seric CA 19.9 levels in patients with non tumoral pathologies. Our experience in 892 cases. Bull Cancer. 73:256–259. 1986.PubMed/NCBI | |
|
Gupta MK, Arciaga R, Bocci L, Tubbs R, Bukowski R and Deodhar SD: Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen. Cancer. 56:277–283. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Haglund C, Roberts PJ, Jalanko H and Kuusela P: Tumour markers CA 19-9 and CA 50 in digestive tract malignancies. Scand J Gastroenterol. 27:169–174. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Loy TS, Sharp SC, Andershock CJ and Craig SB: Distribution of CA 19-9 in adenocarcinomas and transitional cell carcinomas. An immunohistochemical study of 527 cases. Am J Clin Pathol. 99:726–728. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Makovitzky J: The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol. 51:535–544. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Magnani JL, Steplewski Z, Koprowski H and Ginsburg V: Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res. 43:5489–5492. 1983.PubMed/NCBI | |
|
Girgis MD, Kenanova V, Olafsen T, McCabe KE, Wu AM and Tomlinson JS: Anti-CA19-9 diabody as a PET imaging probe for pancreas cancer. J Surg Res. 170:169–178. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sawada R, Sun SM, Wu X, Hong F, Ragupathi G, Livingston PO and Scholz WW: Human monoclonal antibodies to sialyl-Lewis (CA19.9) with potent CDC, ADCC, and antitumor activity. Clin Cancer Res. 17:1024–1032. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Houghton JL, Zeglis BM, Abdel-Atti D, Aggeler R, Sawada R, Agnew BJ, Scholz WW and Lewis JS: Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer. Proc Natl Acad Sci USA. 112:15850–15855. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li CH, Kuo TR, Su HJ, Lai WY, Yang PC, Chen JS, Wang DY, Wu YC and Chen CC: Fluorescence-guided probes of aptamer-targeted gold nanoparticles with computed tomography imaging accesses for in vivo tumor resection. Sci Rep. 5:156752015. View Article : Google Scholar : PubMed/NCBI | |
|
Góra J and Latajka R: Involvement of cysteine proteases in cancer. Curr Med Chem. 22:944–957. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ofori LO, Withana NP, Prestwood TR, Verdoes M, Brady JJ, Winslow MM, Sorger J and Bogyo M: Design of protease activated optical contrast agents that exploit a latent lysosomotropic effect for use in fluorescence-guided surgery. ACS Chem Biol. 10:1977–1988. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kelemen LE: The role of folate receptor alpha in cancer development, progression and treatment: Cause, consequence or innocent bystander? Int J Cancer. 119:243–250. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Low PS and Antony AC: Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv Drug Deliv Rev. 56:1055–1058. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Low PS, Henne WA and Doorneweerd DD: Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res. 41:120–129. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Low PS and Kularatne SA: Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol. 13:256–262. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Y, Sega E and Low PS: Folate receptor-targeted immunotherapy: Induction of humoral and cellular immunity against hapten-decorated cancer cells. Int J Cancer. 116:710–719. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Y, Xu LC, Parker N, Westrick E, Reddy JA, Vetzel M, Low PS and Leamon CP: Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice. Mol Cancer Ther. 5:3258–3267. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
O'Shannessy DJ, Yu G, Smale R, Fu YS, Singhal S, Thiel RP, Somers EB and Vachani A: Folate receptor alpha expression in lung cancer: Diagnostic and prognostic significance. Oncotarget. 3:414–425. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
De Jesus E, Keating JJ, Kularatne SA, Jiang J, Judy R, Predina J, Nie S, Low P and Singhal S: Comparison of folate receptor targeted optical contrast agents for intraoperative molecular imaging. Int J Mol Imaging. 2015:4690472015. View Article : Google Scholar : PubMed/NCBI | |
|
Srinivasarao M, Galliford CV and Low PS: Principles in the design of ligand-targeted cancer therapeutics and imaging agents. Nat Rev Drug Discov. 14:203–219. 2015. View Article : Google Scholar : PubMed/NCBI |
